# MediciNova (MNOV) — Overview

MNOV · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mnov

## Price

Last close $1.45 on Oct 15, 2026. 52-week range $1.18 – $3.45.

## Company profile

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $920,481.00 |
| Revenue (quarter) | $458,439.00 |
| Revenue growth (year over year) | 240.60% |
| Gross profit (trailing twelve months) | $347,443.00 |
| Gross margin | 37.75% |
| Net income (trailing twelve months) | −$10.8M |
| Net income (quarter) | −$2.3M |
| Net income growth (year over year) | 29.47% |
| Net margin | -1168.20% |
| Return on equity | -25.56% |
| EPS (trailing twelve months) | −$0.21 |
| Book value per share | $0.76 |
| P/E (trailing twelve months) | — |
| Price to book | 1.9 |
| Debt to assets | 7.82% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is MediciNova (MNOV) profitable?

No. MediciNova reported a net loss of $10.8M over the trailing twelve months.

### How much revenue does MediciNova (MNOV) make?

MediciNova generated $920,481.00 in revenue over the trailing twelve months, up 240.60% year over year.

### How do I buy stock in MediciNova (MNOV)?

MNOV trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).